Breaking
Alumis’s Envudeucitinib Fails to Meet Primary Endpoints in Phase 2b Lupus Trial, Shares Plunge Amid Broader TYK2 Inhibitor Challenges
Novartis’s Remibrutinib Emerges as a Differentiated BTK Inhibitor, Evading Liver Safety Concerns Plaguing Rivals in the Autoimmune Landscape
Brazilian Research Identifies Molecular Mechanisms of Early Nerve Invasion in Pancreatic Cancer Offering New Targets for Precision Medicine
Stanford Medicine Pioneers Revolutionary Antibody Therapy, Eliminating Toxic Conditioning for Stem Cell Transplants
Breakthrough in Personalized Oncology: German and Chinese Scientists Develop IPTO Model to Revolutionize Brain Tumor Treatment and Drug Testing
Moments That Matter: The Evolution of Childhood Cancer Advocacy and the Search for Normalcy
CureSearch Names Dr. John Prensner as 2025 Young Investigator Awardee to Advance Research in Atypical Teratoid Rhabdoid Tumors
Northwestern University Scientists Develop Groundbreaking Human Spinal Cord Injury Model, Offering New Hope for Regenerative Therapies
Research discovery halts childhood brain tumor before it forms
Shingles Vaccine Linked to Significantly Reduced Dementia Risk in Older Adults Post-Skilled Nursing Facility Admission, New Study Reveals
2 Sep 2026, Wed

immunology

You Missed

Biotech, Pharma & Cancer Drug Development

Alumis’s Envudeucitinib Fails to Meet Primary Endpoints in Phase 2b Lupus Trial, Shares Plunge Amid Broader TYK2 Inhibitor Challenges

Biotech, Pharma & Cancer Drug Development

Novartis’s Remibrutinib Emerges as a Differentiated BTK Inhibitor, Evading Liver Safety Concerns Plaguing Rivals in the Autoimmune Landscape

Genitourinary, Prostate & Kidney Cancer

Brazilian Research Identifies Molecular Mechanisms of Early Nerve Invasion in Pancreatic Cancer Offering New Targets for Precision Medicine

Hematology, Leukemia & Lymphoma

Stanford Medicine Pioneers Revolutionary Antibody Therapy, Eliminating Toxic Conditioning for Stem Cell Transplants